drugset / Trial / NCT06267820
Combined Ketorolac Bupivacaine Versus Bupivacaine Alone for TAP Block in Children Undergoing Lower Abdominal Surgeries
RandomizedParallel-groupQuadruple-blindHealth-services research
Summary
Control of of pain in children is fundamental. TAP block is associated with less side effects compared with other neuraxial techniques especially when done under ultrasound guidance. Ketorolac has analgesic effect comparable to morphine. Children were arranged randomly into two equal groups, forty-five children in each. Group (K) (n= 45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg) and ketorolac (0.5 mg/kg). Group (T) (n =45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg)
Timeline
- Start
- 2023-06-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | — |
| Comparator | Bupivacaine | Other / unclassified | 0.5 unknown | — |
| Comparator | Ketorolac | Other / unclassified | 0.5 mg/kg | — |
Indications
No indication recorded.